Yayın:
A Review on FDA Approved Anti-HIV-1 Drugs, Anti-Gag Compounds and Potential Strategies for HIV-1 Eradication

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBelgin Sever
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorHalil I. Ciftci
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0002-9796-7669
dc.date.accessioned2025-11-13T09:50:30Z
dc.date.issued2024-01-18
dc.identifier.doihttps://doi.org/10.20944/preprints202401.1357.v1
dc.identifier.openalexW4391031704
dc.identifier.urihttps://hdl.handle.net/11421/2352
dc.identifier.urihttps://doi.org/10.20944/preprints202401.1357.v1
dc.language.isoen
dc.relation.ispartofPreprints.org
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectHuman immunodeficiency virus (HIV)
dc.subjectCart
dc.subjectDrug
dc.subjectAntiretroviral therapy
dc.subjectVirology
dc.subjectDrug resistance
dc.subjectImmunology
dc.subjectPharmacology
dc.subjectIntensive care medicine
dc.subjectViral load
dc.subjectBiology
dc.titleA Review on FDA Approved Anti-HIV-1 Drugs, Anti-Gag Compounds and Potential Strategies for HIV-1 Eradication
dc.typereview
dspace.entity.typePublication
local.authorid.openalexA5040352588

Dosyalar

Koleksiyonlar

Publications